A global scheme designed to ensure fair access to COVID-19 vaccines will this month for the first time distribute shots only to countries with the lowest levels of coverage, the World Health Organization said.
Co-led by the WHO, COVAX has since January largely allocated doses proportionally among its 140-plus beneficiary states according to population size.
This made some richer nations that had already secured vaccines through separate deals with pharmaceutical firms eligible for COVAX doses alongside countries with no supplies at all.
For the latest headlines, follow our Google News channel online or via the app.
With some nations administering booster shots while others are still giving first jabs to the most vulnerable, the WHO has now tweaked the rules.
“For the October supply we designed a different methodology, only covering participants with low sources of supply,” Mariangela Simao, WHO Assistant Director General for Access to Vaccines, said in a recording of a conference presentation last week posted on the WHO’s website.
The change comes 15 months after the launch of the COVAX program and as WHO head Tedros Adhanom Ghebreyesus seeks renomination.
Slides from Simao’s presentation showed that, of the more than 90 poorer nations served by COVAX, about half had immunized less than 20 percent of their populations and 26 less than 10 percent. Many wealthy nations reached 70 percent coverage during the northern hemisphere summer.
About 75 million doses of Pfizer, AstraZeneca, Johnson & Johnson, Moderna, and Sinopharm vaccines will be distributed in October to 49 countries considered among the least covered, the slides showed, without indicating the recipient nations.
Alfred Driwale, Program Manager at the Uganda National Expanded Program on Immunizations, told Reuters that the new methodology was welcome but should have been adopted at the start of the program.
The Pan American Health Organization’s (PAHO) assistant director, Jarbas Barbosa, called the switch good news.
However, subsequent rounds of allocations this year are expected to be conducted under different criteria, the slides also showed.
COVAX has so far overseen the allotment of over 500 million shots, of which about 300 million have been shipped to recipient countries.
Russia posts record COVID-19 deaths for fourth straight day, highest cases since JulyRussia on Friday reported a high for coronavirus deaths for a fourth day running as infections continue to surge.A government tally reported 887 ... Coronavirus
Merck’s COVID-19 experimental pill cuts death risk, hospitalization by 50 pct: StudyMerck & Co Inc’s experimental oral drug for COVID-19, molnupiravir, reduced by around 50 percent the chance of hospitalization or death for patients ... Coronavirus
Possible link between COVID-19 vaccine and deep vein blood clots: EU regulatorThe European Union’s drug regulator said on Friday there is a possible link between rare cases of bloods clots in deep veins with Johnson & Johnson’s ... World News
Egypt receives first 1.6 mln doses of Pfizer COVID-19 vaccine from USEgypt on Thursday received 1.6 million doses of the COVID-19 vaccine produced by Pfizer as a gift from the United States as part of the COVAX ... Coronavirus
G7 ministers set to meet on reopening international travel amid COVID-19Transport and health ministers of the G7 countries are due to meet virtually on Thursday to discuss ways to restart international travel, according to ... Coronavirus
Trial to use rotten eggs to see if Vitamin A can help COVID-19 patients regain smellUK researchers are conducting a landmark trial to see if Vitamin A can help treat COVID-19 patients who experienced a loss of smell.The Apollo trial – ... Coronavirus
New storybook to help children stay hopeful, manage mental health fallout of COVID-19A newly-released storybook aims to help children stay hopeful and positive during the COVID-19 pandemic, amid concerns that millions of youth around ... Coronavirus